Global Hepatitis B Therapeutics Industry Research Report 2020, Forecast to 2025

June 2020 | 104 pages | ID: GD97F6063F6CEN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Hepatitis B Therapeutics market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Hepatitis B Therapeutics is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Hepatitis B Therapeutics industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Hepatitis B Therapeutics by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Hepatitis B Therapeutics market are discussed.

The market is segmented by types:

• Hepatitis B Vaccine
• Anti-viral Drugs

It can be also divided by applications:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

And this report covers the historical situation, present status and the future prospects of the global Hepatitis B Therapeutics market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• GlaxoSmithKline
• Merck
• Johnson & Johnson
• Bristol-Myers Squibb
• Novartis
• Novira Therapeutics
• F. Hoffmann%li%La Roche
• Abivax

Report Includes:

• xx data tables and xx additional tables
• An overview of global Hepatitis B Therapeutics market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Hepatitis B Therapeutics market
• Profiles of major players in the industry, including GlaxoSmithKline, Merck, Johnson & Johnson, Bristol-Myers Squibb, Novartis.....

Research objectives

• To study and analyze the global Hepatitis B Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Hepatitis B Therapeutics market by identifying its various subsegments.
• Focuses on the key global Hepatitis B Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Hepatitis B Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Hepatitis B Therapeutics submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Hepatitis B Therapeutics Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Hepatitis B Therapeutics Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 HEPATITIS B THERAPEUTICS INDUSTRY OVERVIEW

2.1 Global Hepatitis B Therapeutics Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Hepatitis B Therapeutics Global Import Market Analysis
  2.1.2 Hepatitis B Therapeutics Global Export Market Analysis
  2.1.3 Hepatitis B Therapeutics Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Hepatitis B Vaccine
  2.2.2 Anti-viral Drugs
2.3 Market Analysis by Application
  2.3.1 Hospital Pharmacies
  2.3.2 Retail Pharmacies
  2.3.3 Online Pharmacies
2.4 Global Hepatitis B Therapeutics Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Hepatitis B Therapeutics Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Hepatitis B Therapeutics Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Hepatitis B Therapeutics Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Hepatitis B Therapeutics Manufacturer Market Share
  2.4.5 Top 10 Hepatitis B Therapeutics Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Hepatitis B Therapeutics Market
  2.4.7 Key Manufacturers Hepatitis B Therapeutics Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Hepatitis B Therapeutics Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Hepatitis B Therapeutics Industry Impact
  2.7.1 How the Covid-19 is Affecting the Hepatitis B Therapeutics Industry
  2.7.2 Hepatitis B Therapeutics Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Hepatitis B Therapeutics Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Hepatitis B Therapeutics Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL HEPATITIS B THERAPEUTICS MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Hepatitis B Therapeutics Sales Market Share by Region
4.2 Global Hepatitis B Therapeutics Revenue Market Share by Region (2015-2019)
4.3 Global Hepatitis B Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Hepatitis B Therapeutics Market Size Detail
  4.4.1 North America Hepatitis B Therapeutics Sales Growth Rate (2015-2020)
  4.4.2 North America Hepatitis B Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Hepatitis B Therapeutics Market Size Detail
  4.5.1 Europe Hepatitis B Therapeutics Sales Growth Rate (2015-2020)
  4.5.2 Europe Hepatitis B Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Hepatitis B Therapeutics Market Size Detail
  4.6.1 Japan Hepatitis B Therapeutics Sales Growth Rate (2015-2020)
  4.6.2 Japan Hepatitis B Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Hepatitis B Therapeutics Market Size Detail
  4.7.1 China Hepatitis B Therapeutics Sales Growth Rate (2015-2020)
  4.7.2 China Hepatitis B Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL HEPATITIS B THERAPEUTICS MARKET SEGMENT BY TYPE

5.1 Global Hepatitis B Therapeutics Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Hepatitis B Therapeutics Sales and Market Share by Type (2015-2020)
  5.1.2 Global Hepatitis B Therapeutics Revenue and Market Share by Type (2015-2020)
5.2 Hepatitis B Vaccine Sales Growth Rate and Price
  5.2.1 Global Hepatitis B Vaccine Sales Growth Rate (2015-2020)
  5.2.2 Global Hepatitis B Vaccine Price (2015-2020)
5.3 Anti-viral Drugs Sales Growth Rate and Price
  5.3.1 Global Anti-viral Drugs Sales Growth Rate (2015-2020)
  5.3.2 Global Anti-viral Drugs Price (2015-2020)

6 GLOBAL HEPATITIS B THERAPEUTICS MARKET SEGMENT BY APPLICATION

6.1 Global Hepatitis B TherapeuticsSales Market Share by Application (2015-2020)
6.2 Hospital Pharmacies Sales Growth Rate (2015-2020)
6.3 Retail Pharmacies Sales Growth Rate (2015-2020)
6.4 Online Pharmacies Sales Growth Rate (2015-2020)

7 GLOBAL HEPATITIS B THERAPEUTICS MARKET FORECAST

7.1 Global Hepatitis B Therapeutics Sales, Revenue Forecast
  7.1.1 Global Hepatitis B Therapeutics Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Hepatitis B Therapeutics Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Hepatitis B Therapeutics Price and Trend Forecast (2020-2025)
7.2 Global Hepatitis B Therapeutics Sales Forecast by Region (2020-2025)
  7.2.1 North America Hepatitis B Therapeutics Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Hepatitis B Therapeutics Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Hepatitis B Therapeutics Production, Revenue Forecast (2020-2025)
  7.2.4 China Hepatitis B Therapeutics Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF HEPATITIS B THERAPEUTICS INDUSTRY KEY MANUFACTURERS

8.1 GlaxoSmithKline
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 GlaxoSmithKline Hepatitis B Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 GlaxoSmithKline News
8.2 Merck
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Merck Hepatitis B Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Merck News
8.3 Johnson & Johnson
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Johnson & Johnson Hepatitis B Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Johnson & Johnson News
8.4 Bristol-Myers Squibb
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Bristol-Myers Squibb Hepatitis B Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Bristol-Myers Squibb News
8.5 Novartis
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Novartis Hepatitis B Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Novartis News
8.6 Novira Therapeutics
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Novira Therapeutics Hepatitis B Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Novira Therapeutics News
8.7 F. Hoffmann- La Roche
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 F. Hoffmann- La Roche Hepatitis B Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 F. Hoffmann- La Roche News
8.8 Abivax
  8.8.1 Company Details
  8.8.2 Product Information
  8.8.3 Abivax Hepatitis B Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.8.4 Main Business Overview
  8.8.5 Abivax News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Hepatitis B Therapeutics Picture
Figure Research Programs/Design for This Report
Figure Global Hepatitis B Therapeutics Market by Regions (2019)
Table Global Market Hepatitis B Therapeutics Comparison by Regions (M USD) 2019-2025
Table Global Hepatitis B Therapeutics Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Hepatitis B Therapeutics by Type in 2019
Figure Hepatitis B Vaccine Picture
Figure Anti-viral Drugs Picture
Table Global Hepatitis B Therapeutics Sales by Application (2019-2025)
Figure Global Hepatitis B Therapeutics Sales Market Share by Application in 2019
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Hepatitis B Therapeutics Sales by Manufacturer (2018-2020)
Figure Global Hepatitis B Therapeutics Sales Market Share by Manufacturer in 2019
Table Global Hepatitis B Therapeutics Revenue by Manufacturer (2018-2020)
Figure Global Hepatitis B Therapeutics Revenue Market Share by Manufacturer in 2019
Table Global Hepatitis B Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Hepatitis B Therapeutics Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Hepatitis B Therapeutics Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Hepatitis B Therapeutics Market
Table Key Manufacturers Hepatitis B Therapeutics Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hepatitis B Therapeutics
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Hepatitis B Therapeutics Sales (K Units) by Region (2015-2020)
Table Global Hepatitis B Therapeutics Sales Market Share by Region (2015-2019)
Figure Global Hepatitis B Therapeutics Sales Market Share by Region (2015-2019)
Figure Global Hepatitis B Therapeutics Sales Market Share by Region in 2018
Table Global Hepatitis B Therapeutics Revenue (Million US$) by Region (2015-2020)
Table Global Hepatitis B Therapeutics Revenue Market Share by Region (2015-2020)
Figure Global Hepatitis B Therapeutics Revenue Market Share by Region (2015-2020)
Figure Global Hepatitis B Therapeutics Revenue Market Share by Region in 2019
Table Global Hepatitis B Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Hepatitis B Therapeutics Sales (K Units) Growth Rate (2015-2020)
Table North America Hepatitis B Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Hepatitis B Therapeutics Sales (K Units) Growth Rate (2015-2020)
Table Europe Hepatitis B Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Hepatitis B Therapeutics Sales (K Units) Growth Rate (2015-2020)
Table Japan Hepatitis B Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Hepatitis B Therapeutics Sales (K Units) Growth Rate (2015-2020)
Table China Hepatitis B Therapeutics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Hepatitis B Therapeutics Sales by Type (2015-2020)
Table Global Hepatitis B Therapeutics Sales Market Share by Type (2015-2020)
Figure Global Hepatitis B Therapeutics Sales Market Share by Type in 2019
Table Global Hepatitis B Therapeutics Revenue by Type (2015-2020)
Table Global Hepatitis B Therapeutics Revenue Market Share by Type (2015-2020)
Figure Global Hepatitis B Therapeutics Revenue Market Share by Type in 2019
Figure Global Hepatitis B Vaccine Sales Growth Rate (2015-2020)
Figure Global Hepatitis B Vaccine Price (2015-2020)
Figure Global Anti-viral Drugs Sales Growth Rate (2015-2020)
Figure Global Anti-viral Drugs Price (2015-2020)
Table Global Hepatitis B Therapeutics Sales by Application (2015-2020)
Table Global Hepatitis B Therapeutics Sales Market Share by Application (2015-2020)
Figure Global Hepatitis B Therapeutics Sales Market Share by Application in 2019
Figure Global Hospital Pharmacies Sales Growth Rate (2015-2020)
Figure Global Retail Pharmacies Sales Growth Rate (2015-2020)
Figure Global Online Pharmacies Sales Growth Rate (2015-2020)
Figure Global Hepatitis B Therapeutics Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Hepatitis B Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Hepatitis B Therapeutics Price and Trend Forecast (2020-2025)
Table Global Hepatitis B Therapeutics Sales (K Units) Forecast by Region (2020-2025)
Figure Global Hepatitis B Therapeutics Production Market Share Forecast by Region (2020-2025)
Figure North America Hepatitis B Therapeutics Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Hepatitis B Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Hepatitis B Therapeutics Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Hepatitis B Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Hepatitis B Therapeutics Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Hepatitis B Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Hepatitis B Therapeutics Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Hepatitis B Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table GlaxoSmithKline Company Profile
Figure Hepatitis B Therapeutics Product Picture and Specifications of GlaxoSmithKline
Table Hepatitis B Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure GlaxoSmithKline Hepatitis B Therapeutics Market Share (2018-2020)
Table GlaxoSmithKline Main Business
Table GlaxoSmithKline Recent Development
Table Merck Company Profile
Figure Hepatitis B Therapeutics Product Picture and Specifications of Merck
Table Hepatitis B Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Merck Hepatitis B Therapeutics Market Share (2018-2020)
Table Merck Main Business
Table Merck Recent Development
Table Johnson & Johnson Company Profile
Figure Hepatitis B Therapeutics Product Picture and Specifications of Johnson & Johnson
Table Hepatitis B Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Johnson & Johnson Hepatitis B Therapeutics Market Share (2018-2020)
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Bristol-Myers Squibb Company Profile
Figure Hepatitis B Therapeutics Product Picture and Specifications of Bristol-Myers Squibb
Table Hepatitis B Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bristol-Myers Squibb Hepatitis B Therapeutics Market Share (2018-2020)
Table Bristol-Myers Squibb Main Business
Table Bristol-Myers Squibb Recent Development
Table Novartis Company Profile
Figure Hepatitis B Therapeutics Product Picture and Specifications of Novartis
Table Hepatitis B Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Novartis Hepatitis B Therapeutics Market Share (2018-2020)
Table Novartis Main Business
Table Novartis Recent Development
Table Novira Therapeutics Company Profile
Figure Hepatitis B Therapeutics Product Picture and Specifications of Novira Therapeutics
Table Hepatitis B Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Novira Therapeutics Hepatitis B Therapeutics Market Share (2018-2020)
Table Novira Therapeutics Main Business
Table Novira Therapeutics Recent Development
Table F. Hoffmann- La Roche Company Profile
Figure Hepatitis B Therapeutics Product Picture and Specifications of F. Hoffmann- La Roche
Table Hepatitis B Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure F. Hoffmann- La Roche Hepatitis B Therapeutics Market Share (2018-2020)
Table F. Hoffmann- La Roche Main Business
Table F. Hoffmann- La Roche Recent Development
Table Abivax Company Profile
Figure Hepatitis B Therapeutics Product Picture and Specifications of Abivax
Table Hepatitis B Therapeutics Production, Price, Revenue and Gross Margin of 2018-2020
Figure Abivax Hepatitis B Therapeutics Market Share (2018-2020)
Table Abivax Main Business
Table Abivax Recent Development
Table of Appendix